ARBITEL TRIO 25

Description

Arbitel-Trio 25 Tablet ER, manufactured by Micro Labs Ltd., is prescribed when single or dual antihypertensive therapies are insufficient. The combination of Cilnidipine, Metoprolol Succinate, and Telmisartan provides a comprehensive approach to controlling blood pressure.

• Cilnidipine (10 mg): A calcium channel blocker that relaxes and widens blood vessels, reducing vascular resistance.

• Metoprolol Succinate (25 mg): A cardioselective beta-blocker that decreases heart rate and the force of heart contractions, lowering blood pressure.

• Telmisartan (40 mg): An angiotensin II receptor blocker that prevents blood vessel constriction, aiding in blood pressure reduction.

This combination therapy not only effectively lowers blood pressure but also reduces the risk of heart-related complications such as stroke and heart attack.

Dosage & Administration:

• Dosage: Typically, one tablet daily, as prescribed by a healthcare provider.

• Administration: Swallow the tablet whole with a glass of water; do not chew or crush.

• With or Without Food: Can be taken with or without food.

Side Effects:

Common side effects may include:

• Dizziness or lightheadedness

• Fatigue

• Headache

• Nausea or diarrhea

• Increased urination

• Ankle swelling

• Flushing (sense of warmth in the face, ears, neck, and trunk)

• Cold extremities

• Slow heart rate (bradycardia)

• Numbness of extremity

• Decreased blood pressure

Precautions:

• Pregnancy & Breastfeeding: Not recommended during pregnancy or breastfeeding.

• Kidney or Liver Disease: Use with caution; dose adjustments may be necessary.

• Electrolyte Imbalances: Monitor potassium and sodium levels regularly.

• Alcohol Consumption: Limit intake as alcohol can enhance side effects like dizziness.